Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03ZZX
|
|||
| Former ID |
DIB005821
|
|||
| Drug Name |
123I-MNI-420
|
|||
| Synonyms |
123I-SPECT diagnostic (Parkinson's/Huntington's disease), IND; 123I-SPECT imaging marker, IND
Click to Show/Hide
|
|||
| Indication | Huntington disease [ICD-11: 8A01.10; ICD-10: G10; ICD-9: 294.1, 333.4] | Phase 1 | [1] | |
| Company |
Institute for Neurodegenerative Disorders
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00970229) Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.